Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia Infections | 38 | 2024 | 200 | 7.680 |
Why?
|
| Bacterial Vaccines | 23 | 2024 | 129 | 6.800 |
Why?
|
| Chlamydia trachomatis | 21 | 2024 | 70 | 4.340 |
Why?
|
| Chlamydia | 16 | 2024 | 45 | 3.970 |
Why?
|
| Vibrio cholerae | 15 | 2021 | 105 | 2.270 |
Why?
|
| Antibodies, Bacterial | 13 | 2024 | 117 | 2.000 |
Why?
|
| Dendritic Cells | 11 | 2021 | 132 | 1.790 |
Why?
|
| Porins | 6 | 2019 | 19 | 1.640 |
Why?
|
| Chlamydia muridarum | 8 | 2021 | 104 | 1.450 |
Why?
|
| Mice | 40 | 2024 | 6644 | 1.240 |
Why?
|
| Antigens, Bacterial | 9 | 2024 | 144 | 0.990 |
Why?
|
| Mice, Inbred C57BL | 24 | 2023 | 1869 | 0.990 |
Why?
|
| Th1 Cells | 11 | 2019 | 97 | 0.980 |
Why?
|
| Membrane Proteins | 4 | 2021 | 561 | 0.970 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2017 | 57 | 0.940 |
Why?
|
| Animals | 48 | 2024 | 16992 | 0.910 |
Why?
|
| Vaccines, Subunit | 9 | 2024 | 34 | 0.890 |
Why?
|
| Bacterial Proteins | 5 | 2020 | 595 | 0.880 |
Why?
|
| Immunity, Mucosal | 7 | 2021 | 53 | 0.870 |
Why?
|
| Chlamydophila psittaci | 2 | 2021 | 2 | 0.860 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2024 | 13 | 0.840 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2024 | 60 | 0.810 |
Why?
|
| Psittacosis | 2 | 2021 | 2 | 0.740 |
Why?
|
| Chitosan | 1 | 2021 | 53 | 0.670 |
Why?
|
| Immunity, Innate | 4 | 2017 | 171 | 0.650 |
Why?
|
| Adjuvants, Immunologic | 7 | 2017 | 117 | 0.630 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 5 | 0.620 |
Why?
|
| Female | 37 | 2024 | 24698 | 0.590 |
Why?
|
| MicroRNAs | 4 | 2021 | 518 | 0.580 |
Why?
|
| Interleukin-1beta | 2 | 2017 | 75 | 0.560 |
Why?
|
| Cholera Toxin | 3 | 2024 | 41 | 0.550 |
Why?
|
| Cross Protection | 2 | 2015 | 5 | 0.540 |
Why?
|
| Cholera | 3 | 2011 | 74 | 0.540 |
Why?
|
| Antigen Presentation | 5 | 2017 | 58 | 0.520 |
Why?
|
| Administration, Intranasal | 4 | 2024 | 89 | 0.520 |
Why?
|
| Vaccines, Synthetic | 6 | 2015 | 80 | 0.520 |
Why?
|
| Interferon-gamma | 5 | 2024 | 269 | 0.500 |
Why?
|
| Signal Transduction | 5 | 2020 | 2157 | 0.480 |
Why?
|
| Nanoparticles | 1 | 2021 | 460 | 0.460 |
Why?
|
| Vagina | 5 | 2023 | 89 | 0.460 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 1596 | 0.380 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2024 | 65 | 0.360 |
Why?
|
| Immunoglobulin G | 4 | 2024 | 259 | 0.360 |
Why?
|
| Immunologic Memory | 2 | 2011 | 42 | 0.360 |
Why?
|
| Drug Evaluation | 1 | 2011 | 10 | 0.350 |
Why?
|
| Trachoma | 1 | 2010 | 2 | 0.330 |
Why?
|
| Blindness | 1 | 2010 | 19 | 0.320 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 209 | 0.320 |
Why?
|
| Th2 Cells | 2 | 2020 | 62 | 0.310 |
Why?
|
| Immunoglobulin A | 3 | 2019 | 65 | 0.300 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2020 | 16 | 0.300 |
Why?
|
| Cholera Vaccines | 3 | 2007 | 18 | 0.280 |
Why?
|
| Genitalia | 2 | 2019 | 18 | 0.280 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 22 | 0.270 |
Why?
|
| Drug Delivery Systems | 4 | 2007 | 277 | 0.270 |
Why?
|
| Genetic Vectors | 5 | 2011 | 165 | 0.270 |
Why?
|
| Vaginal Diseases | 1 | 2007 | 9 | 0.270 |
Why?
|
| Hela Cells | 6 | 2018 | 376 | 0.260 |
Why?
|
| Viral Vaccines | 2 | 2006 | 37 | 0.260 |
Why?
|
| Vaccination | 4 | 2021 | 355 | 0.260 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 21 | 0.260 |
Why?
|
| Herpesvirus 2, Human | 1 | 2006 | 10 | 0.260 |
Why?
|
| Herpes Genitalis | 1 | 2006 | 7 | 0.260 |
Why?
|
| Immunity, Cellular | 4 | 2017 | 74 | 0.250 |
Why?
|
| NF-kappa B | 2 | 2020 | 358 | 0.240 |
Why?
|
| Viral Envelope Proteins | 1 | 2006 | 91 | 0.240 |
Why?
|
| Caspase 1 | 2 | 2017 | 16 | 0.240 |
Why?
|
| Interleukin-10 | 5 | 2017 | 87 | 0.230 |
Why?
|
| Mice, Inbred CBA | 1 | 2024 | 42 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 458 | 0.220 |
Why?
|
| Humans | 22 | 2024 | 43102 | 0.220 |
Why?
|
| Vaccines, Combined | 3 | 2011 | 12 | 0.210 |
Why?
|
| Ruminants | 1 | 2023 | 7 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 127 | 0.210 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 53 | 0.200 |
Why?
|
| Epitopes | 1 | 2024 | 157 | 0.200 |
Why?
|
| Fertility | 3 | 2015 | 62 | 0.200 |
Why?
|
| Pelvic Inflammatory Disease | 2 | 2020 | 19 | 0.190 |
Why?
|
| Chickens | 2 | 2021 | 161 | 0.190 |
Why?
|
| T-Lymphocytes | 4 | 2015 | 386 | 0.190 |
Why?
|
| Pregnancy | 4 | 2023 | 1772 | 0.190 |
Why?
|
| Computer Simulation | 1 | 2024 | 408 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 216 | 0.170 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 704 | 0.160 |
Why?
|
| Genital Diseases, Female | 4 | 2007 | 38 | 0.160 |
Why?
|
| Avian Proteins | 1 | 2020 | 12 | 0.160 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2020 | 28 | 0.160 |
Why?
|
| Mice, Knockout | 10 | 2017 | 1035 | 0.160 |
Why?
|
| Lymphocyte Activation | 5 | 2014 | 249 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2009 | 91 | 0.160 |
Why?
|
| Infertility, Female | 2 | 2013 | 24 | 0.150 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2019 | 5 | 0.150 |
Why?
|
| Antibody Formation | 3 | 2011 | 76 | 0.150 |
Why?
|
| Spleen | 2 | 2010 | 204 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2017 | 1621 | 0.150 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 236 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2020 | 434 | 0.130 |
Why?
|
| Administration, Rectal | 1 | 2017 | 18 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 224 | 0.130 |
Why?
|
| Cell Line | 5 | 2020 | 1410 | 0.130 |
Why?
|
| Fibrosis | 1 | 2017 | 169 | 0.130 |
Why?
|
| Vaccines, DNA | 3 | 2013 | 24 | 0.130 |
Why?
|
| Macrophages | 2 | 2020 | 529 | 0.130 |
Why?
|
| Toll-Like Receptors | 2 | 2015 | 51 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 411 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2017 | 883 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 223 | 0.110 |
Why?
|
| Cytokines | 4 | 2017 | 678 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2015 | 50 | 0.110 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 29 | 0.110 |
Why?
|
| Proteomics | 3 | 2017 | 378 | 0.110 |
Why?
|
| Gram-Negative Bacteria | 2 | 2004 | 29 | 0.100 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 64 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 561 | 0.100 |
Why?
|
| Mucous Membrane | 3 | 2008 | 34 | 0.100 |
Why?
|
| Bacteriophage lambda | 1 | 2013 | 12 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2015 | 321 | 0.100 |
Why?
|
| Chlamydiaceae Infections | 1 | 2012 | 3 | 0.100 |
Why?
|
| Receptors, Fc | 2 | 2003 | 7 | 0.100 |
Why?
|
| Calcitriol | 1 | 2012 | 32 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 227 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 69 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 117 | 0.090 |
Why?
|
| Virus Shedding | 1 | 2010 | 9 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2011 | 78 | 0.080 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 18 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 109 | 0.080 |
Why?
|
| Photoperiod | 2 | 2020 | 27 | 0.080 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2009 | 12 | 0.080 |
Why?
|
| Inclusion Bodies | 2 | 2020 | 34 | 0.080 |
Why?
|
| Trypanosomiasis, African | 1 | 2009 | 22 | 0.080 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 74 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2011 | 430 | 0.070 |
Why?
|
| Protozoan Vaccines | 2 | 2009 | 16 | 0.070 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2009 | 82 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 694 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1455 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 65 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2005 | 31 | 0.070 |
Why?
|
| Genomics | 1 | 2010 | 293 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2005 | 168 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2007 | 24 | 0.060 |
Why?
|
| Fibronectins | 2 | 2017 | 69 | 0.060 |
Why?
|
| Vero Cells | 1 | 2006 | 112 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1070 | 0.060 |
Why?
|
| Cadherins | 2 | 2017 | 102 | 0.060 |
Why?
|
| Inflammation | 2 | 2013 | 758 | 0.060 |
Why?
|
| Chemokines | 2 | 2003 | 96 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2017 | 462 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 25 | 0.050 |
Why?
|
| Fungal Vaccines | 1 | 2004 | 45 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 67 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 244 | 0.050 |
Why?
|
| Antibodies | 1 | 2004 | 144 | 0.050 |
Why?
|
| Intestines | 1 | 2003 | 71 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 197 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 181 | 0.050 |
Why?
|
| Chlamydophila | 1 | 2003 | 1 | 0.050 |
Why?
|
| Chlamydophila Infections | 1 | 2003 | 1 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 210 | 0.050 |
Why?
|
| Apoptosis | 3 | 2017 | 1568 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 278 | 0.050 |
Why?
|
| Uterus | 1 | 2023 | 52 | 0.050 |
Why?
|
| Diarrhea | 1 | 2003 | 95 | 0.050 |
Why?
|
| Antigens | 1 | 2003 | 59 | 0.050 |
Why?
|
| Cell Wall | 1 | 2003 | 55 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 72 | 0.040 |
Why?
|
| Pregnancy, Ectopic | 1 | 2020 | 15 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 189 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 403 | 0.040 |
Why?
|
| Poultry Diseases | 1 | 2020 | 12 | 0.040 |
Why?
|
| Endocytosis | 1 | 2020 | 118 | 0.040 |
Why?
|
| Myosin Type II | 1 | 2018 | 17 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 701 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 177 | 0.040 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 2 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 7 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 26 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 19 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 60 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 22 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 78 | 0.030 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2017 | 2 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 11 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 57 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 164 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2017 | 25 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 181 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 139 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 934 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 712 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 327 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 25 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2015 | 4 | 0.030 |
Why?
|
| Thrombospondin 1 | 1 | 2015 | 23 | 0.030 |
Why?
|
| Genitalia, Female | 2 | 2007 | 29 | 0.030 |
Why?
|
| Caspases | 1 | 2015 | 148 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 95 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 436 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 150 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 536 | 0.030 |
Why?
|
| Bacteriophage phi X 174 | 2 | 2004 | 11 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 384 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 945 | 0.030 |
Why?
|
| Weaning | 1 | 2013 | 16 | 0.030 |
Why?
|
| Drug Design | 2 | 2006 | 186 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 523 | 0.020 |
Why?
|
| Leukocyte Elastase | 1 | 2012 | 12 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1271 | 0.020 |
Why?
|
| Serpins | 1 | 2012 | 27 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 491 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 212 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 18 | 0.020 |
Why?
|
| Nigeria | 1 | 2011 | 92 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 36 | 0.020 |
Why?
|
| Proteome | 1 | 2012 | 152 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 207 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 735 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 206 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 307 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2009 | 82 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 166 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 41 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 72 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 116 | 0.020 |
Why?
|
| Phylogeny | 1 | 2011 | 769 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2007 | 29 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2005 | 19 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2676 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 638 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 146 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 224 | 0.010 |
Why?
|
| Bacteriolysis | 1 | 2003 | 2 | 0.010 |
Why?
|
| Drug Administration Routes | 1 | 2003 | 14 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 2003 | 41 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 2003 | 75 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 94 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 151 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2002 | 1 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2003 | 113 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2002 | 14 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2002 | 19 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 16 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 260 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 36 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 296 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 41 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 59 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2002 | 38 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 109 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 13872 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 190 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 95 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 5080 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 695 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 6081 | 0.010 |
Why?
|
| Male | 2 | 2013 | 23409 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 8214 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 12222 | 0.010 |
Why?
|